The EU will review all requests for exports A senior EU official said the AstraZeneca PLC was giving the UK a “very serious” vaccine and would probably reject it until the drug manufacturer fulfilled its delivery obligations, a senior EU official said.
Responding to remarks by UK Defense Secretary Ben Wallace on Sunday that the EU must honor its vaccination agreement, the Brussels official said the EU had no obligation to help the EU meet its commitments.
The EU has its own agreement with the company that is not currently being respected, and any vaccines and ingredients produced in European factories will now be reserved for local delivery, the official said, speaking on condition of anonymity because decisions are under consideration. And have not been disclosed.
The European Union (EU) and the United Kingdom (EU) have stated opposition to using force or imposing sanctions on Iran. The line is becoming increasingly toxic, with both sides blaming each other for export restrictions and nationalism, and some fear that the fragile post-Brexit agreement reached in December last year could jeopardize the fragile relationship.
The EU should honor its vaccination agreement even as sluggish rollouts put pressure on governments there, Valce Les told Sky News.
“The commission knows this will be unfavorable,” he said. “They are under tremendous political pressure European Commission. It would hurt EU relations globally if they had to renew on these agreements. “
An EU official said there were no pending requests for UK exports from Astra’s manufacturing facility in the Netherlands, but that such a request would probably be rejected. More than 10 million doses have been exported from the EU to the UK, although officials say very few of these shipments were of the Astra vaccine and its components.
A Dutch spokesman said on Sunday that “the Netherlands in principle allows exports to continue without the permission of the European Commission.” In order to avoid the tipping point that the Commission is indeed taking further action in cooperation with member countries, it is important Both London and AstraZeneca will reach an immediate deal on the vaccine to be developed by the company at the facilities.
– With the help of Suzy Ring